Financial Reports Latest Updates Industry Maps Economic Calendar

Neurogene Inc. (NGNE) Annual Reports

Q: Where can I read Neurogene Inc. (NGNE) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Neurogene Inc. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1404644 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Operating income	$-36.7M	$-26.1M	-40.6%
Net income	$-34.5M	$-22.0M	-56.6%
EPS (diluted)	$-1.53	$-1.05	-45.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 0 mn Net income -34.5 mn

Show table：Income statement

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	25.0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0	0	0	—	0.93	0	0	—	0	0	0	—	—
Operating income	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-37.6	—	-14.0	-12.1	-16.5	—	2.69	-15.2	-5.30	—	-0.43	-59.5	-8.36	-9.07	-9.77	-2.25	-12.6	-14.9	-15.1	-15.4	-15.2	-15.4	-15.9	-13.6	-14.3	-15.1	-3.07	-5.57	-31.8	-18.8	-20.1	-22.2	-21.5	-25.9	-26.1	-23.8	-27.5	-33.4	-36.7
Net income	-7.71	-1.01	-0.81	-3.37	-3.54	-4.23	-5.42	-6.28	-24.0	-6.41	-4.75	-5.03	-5.66	-6.71	-10.9	-8.15	-11.2	-8.32	-13.8	-11.8	-16.3	-14.6	2.92	-15.0	-4.89	-2.21	0	-59.1	-8.10	-8.64	-9.75	-2.25	-12.6	-14.9	-15.1	-15.4	-15.2	-15.3	-15.7	-13.1	-13.4	-14.2	-2.08	-4.53	13.7	-16.9	-18.5	-20.2	-19.5	-22.6	-22.0	-20.9	-24.7	-30.9	-34.5

Balance sheet

Quarterly · In mn (USD)

Total assets 244 mn Total liabilities 27.2 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	15.3	56.3	36.3	40.4	39.3	35.0	29.8	118	74.8	69.5	67.7	147	103	122	132	121	109	94.2	103	87.3	77.2	74.8	73.2	67.6	144	140	131	207	195	181	168	157	144	130	118	109	99.1	85.6	83.8	79.9	200	174	159	144	316	296	279	271	272	247	229
Total assets	—	—	—	—	15.7	56.5	53.0	48.6	41.4	35.1	29.9	118	113	108	101	164	154	143	133	122	110	95.6	104	87.8	77.6	75.4	73.7	69.8	147	153	145	222	211	200	187	176	163	149	137	127	116	98.5	94.0	89.6	223	195	180	164	336	315	297	288	289	263	244
Current liabilities	—	—	—	—	2.62	1.24	2.85	4.57	5.20	4.97	3.98	3.86	4.79	5.72	8.50	8.56	9.52	5.82	8.13	7.00	11.0	9.36	13.3	10.8	4.63	3.60	1.16	2.57	4.74	5.60	6.32	9.89	7.89	8.41	7.58	9.00	8.64	7.60	9.27	10.2	11.1	7.16	4.88	5.21	23.0	11.8	13.1	15.8	15.2	14.1	15.4	14.7	16.4	18.9	21.5
Total liabilities	—	—	—	—	7.48	1.35	2.94	4.64	5.28	5.05	4.05	4.00	4.92	5.83	8.61	8.71	9.72	6.39	8.68	7.51	11.4	9.80	13.8	11.1	4.95	3.89	1.41	2.92	5.34	15.9	16.6	21.4	19.3	21.1	19.9	21.1	20.4	19.0	20.3	20.9	21.6	17.1	14.4	14.3	36.5	24.6	24.8	26.7	25.4	23.5	24.1	22.3	23.7	25.4	27.2
Equity	-51.1	—	—	—	-65.7	55.1	50.0	44.0	36.1	30.1	25.8	114	108	102	92.1	155	145	137	125	114	98.9	85.8	90.7	76.7	72.7	71.5	72.3	66.9	142	137	129	200	191	179	167	155	143	130	117	106	94.3	81.4	79.6	75.2	186	171	155	137	310	292	273	266	265	238	217

Cash flow

Quarterly · In mn (USD)

Operating -23.8 mn Investing 6.10 mn Financing 5.98 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-7.23	-0.9	-1.44	-1.74	-3.85	-3.80	-2.81	-4.18	-7.01	-6.75	-5.34	-4.68	-3.49	-5.87	-7.92	-7.44	-9.00	-11.3	-10.3	-11.5	-11.6	-15.6	9.18	-15.4	-9.77	-2.76	-1.47	-6.53	-4.64	-6.44	-8.79	-0.11	-9.23	-13.4	-13.3	-8.76	-12.2	-14.1	-11.3	-9.29	-10.9	-13.0	-4.05	-4.27	-30.1	-21.6	-15.9	-15.6	-17.5	-20.8	-19.5	-19.5	-17.4	-26.1	-23.8
Investing	-0.01	0.05	0.1	0.03	-2.81	0	-31.8	2.21	6.05	6.06	6.03	6.06	-65.7	2.00	-5.30	-0.05	-44.7	-0.11	16.2	31.5	16.5	30.0	23.0	3.02	0	—	—	0.09	-0.78	-0.11	-0.97	-0.49	-0.65	-1.09	-1.19	-0.59	-0.4	-0.45	-39.3	-27.9	8.47	10.7	-0.41	-1.61	17.0	29.9	-23.6	-29.0	-103	-45.0	7.45	22.0	29.6	46.2	6.10
Financing	—	17.9	-0.09	0	1.81	45.7	-0.39	-0.05	0	0.07	-0.05	93.1	-0.15	—	0	71.3	-0.16	0	0.37	0	0.05	0.2	0.4	-0.02	0	0	0	0.04	82.2	3.39	0.3	72.2	1.29	0.28	0.31	0.03	0.11	0.13	0.06	-0.05	0.02	-0.07	-0.29	0	92.8	-6.52	0.4	0.13	190	0	0.05	9.71	20.7	0.2	5.98
Cash at period end	2.00	19.0	17.6	15.9	11.0	52.9	17.9	15.9	14.9	14.3	14.9	109	39.5	35.7	22.5	86.2	32.3	20.9	27.1	47.1	52.0	66.6	99.1	86.7	76.9	74.2	72.7	66.3	143	139	130	201	193	178	164	155	142	128	77.5	40.3	37.9	35.5	31.1	25.2	148	150	111	66.6	137	70.8	58.8	71.0	104	124	112

Profitability

Quarterly · %

Operating margin -2176.7% Net margin -1999.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	10.8%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2176.7%	—	—	—	—	—	—	—	—
Net margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	11.7%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1999.1%	—	—	—	—	—	—	—	—

Returns & leverage

Quarterly · %

ROE -45.3% ROA -41.0% Debt ratio 11.1%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	-21.7%	-33.1%	-44.3%	—	-99.0%	-109.4%	-50.9%	-30.2%	-33.5%	-48.0%	-23.3%	-29.2%	-32.3%	-38.3%	-33.5%	-41.2%	-50.7%	-37.0%	-45.0%	-36.8%	-24.4%	-27.1%	-92.2%	-64.8%	-72.7%	-85.2%	-21.5%	-20.0%	-25.1%	-30.4%	-32.8%	-36.3%	-39.5%	-43.5%	-45.5%	-48.5%	-53.4%	-43.6%	-37.9%	-5.1%	-7.8%	-22.4%	-39.5%	-30.3%	-35.0%	-39.4%	-42.3%	-31.4%	-37.3%	-45.3%
ROA	—	—	—	—	-55.8%	-21.2%	-31.3%	-40.1%	-140.0%	-92.0%	-100.2%	-48.3%	-28.3%	-30.9%	-43.4%	-22.3%	-27.6%	-30.7%	-35.5%	-31.6%	-37.9%	-47.3%	-33.5%	-41.0%	-33.6%	-22.4%	-24.8%	-84.0%	-61.8%	-66.4%	-78.2%	-19.7%	-18.6%	-22.4%	-27.1%	-29.3%	-32.5%	-35.0%	-38.0%	-39.2%	-41.2%	-45.6%	-37.1%	-31.7%	-4.2%	-6.7%	-19.2%	-33.1%	-26.9%	-31.7%	-35.4%	-37.7%	-28.9%	-34.1%	-41.0%
Debt ratio	—	—	—	—	47.8%	2.4%	5.5%	9.5%	12.7%	14.4%	13.6%	3.4%	4.3%	5.4%	8.6%	5.3%	6.3%	4.5%	6.5%	6.2%	10.4%	10.3%	13.2%	12.6%	6.4%	5.2%	1.9%	4.2%	3.6%	10.4%	11.4%	9.6%	9.2%	10.6%	10.7%	12.0%	12.5%	12.8%	14.8%	16.5%	18.6%	17.4%	15.3%	16.0%	16.4%	12.6%	13.8%	16.3%	7.5%	7.5%	8.1%	7.7%	8.2%	9.6%	11.1%

EPS

Quarterly · US$

EPS US$-1.53

Show table：EPS

Item	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q4	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	-8.48	—	—	—	-1.28	—	—	—	—	—	—	—	—	—	—	—	—	-0.59	—	—	—	0.12	—	—	—	-0.09	—	—	-0.18	-0.20	-0.04	-0.23	-0.27	-0.27	-0.28	-0.27	-0.28	-0.28	-0.24	-0.24	-0.26	-0.04	-0.41	2.93	-1.00	-1.09	-1.19	-0.99	-1.08	-1.05	-0.99	-1.13	-1.39	-1.53

Revenue & profit

Year-to-date · In mn (USD)

Net income -65.4 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 244 mn Total liabilities 27.2 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -49.9 mn Investing 52.3 mn Financing 6.18 mn

Positive = cash in, negative = cash out.

Returns & leverage

Year-to-date · %

ROE -45.3% ROA -41.0% Debt ratio 11.1%

EPS

Year-to-date · US$

EPS US$-2.92

Revenue & profit

Annual · In mn (USD)

Net income -90.3 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating income	—	—	—	—	—	—	-33.7	-60.7	-59.1	-55.6	-82.6	-103
Net income	-8.73	-21.9	-37.0	-50.2	-31.6	-69.4	-33.3	-60.7	-57.6	-7.16	-75.1	-90.3

Balance sheet

Annual · In mn (USD)

Total assets 289 mn Total liabilities 23.7 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	15.3	74.8	103	109	77.2	144	195	144	99.1	200	316	272
Total assets	15.7	113	154	110	77.6	147	211	163	116	223	336	289
Current liabilities	2.62	4.79	9.52	11.0	4.63	4.74	7.89	8.64	11.1	23.0	15.2	16.4
Total liabilities	7.48	4.92	9.72	11.4	4.95	5.34	19.3	20.4	21.6	36.5	25.4	23.7
Equity	-65.7	108	145	98.9	72.7	142	191	143	94.3	186	310	265

Cash flow

Annual · In mn (USD)

Operating -77.2 mn Investing 14.0 mn Financing 30.4 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-7.94	-20.3	-30.2	-44.7	-31.6	-15.4	-24.6	-47.6	-45.6	-51.4	-70.6	-77.2
Investing	-2.64	-47.5	-48.1	64.0	56.0	—	-2.22	-3.26	-59.1	25.6	-125	14.0
Financing	19.6	93.0	—	0.42	0.57	82.2	77.1	0.73	0.16	92.5	184	30.4
Cash at period end	11.0	39.5	32.3	52.0	76.9	143	193	142	37.9	148	137	104

Returns & leverage

Annual · %

ROE -31.4% ROA -28.9% Debt ratio 8.2%

Show table：Returns & leverage

Item	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	-102.3%	-29.2%	-41.2%	-36.8%	-64.8%	-20.0%	-36.3%	-48.5%	-5.1%	-30.3%	-31.4%
ROA	-55.8%	-33.9%	-27.6%	-37.9%	-33.6%	-61.8%	-18.6%	-32.5%	-41.2%	-4.2%	-26.9%	-28.9%
Debt ratio	47.8%	4.3%	6.3%	10.4%	6.4%	3.6%	9.2%	12.5%	18.6%	16.4%	7.5%	8.2%

EPS

Annual · US$

EPS US$-4.25

Show table：EPS

Item	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	-0.65	-1.09	-1.04	2.22	-4.27	-4.25

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Neurogene Inc. (NGNE) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.